Cochrane, an international independent network of 80,000 researchers, professionals, patients, carers and people interested in health is taking this unprecedented move to ensure that Cochrane evidence is accessible for all those involved in combating the pandemic and its effects on global public health.
The Cochrane Libary is the world’s leading resource for systematic reviews in health care, containing more than 10,600 Cochrane Systematic Reviews and protocols; 2,300 Cochrane Clinical Answers (CCAs) providing readable, digestible, clinically-focused guidance for healthcare professionals; 33 ‘Special Collections’ of Reviews curated on specific topics; Editorials; and CENTRAL, one of the world’s largest registers of randomized controlled trials, with over 1.6 million entries.
Over the last two months Cochrane has published:
- Six ‘Special Collections’ of Cochrane evidence relating to the prevention and treatment of COVID-19, containing 106 Cochrane Reviews and 67 Cochrane Clinical Answers (to support decision-making for health professionals). These Special Collections were developed based on World Health Organization (WHO) interim guidance and are updated in response to new information;
- Five Cochrane Rapid Reviews published with accompanying podcasts and six related Cochrane Clinical Answers;
- A full Cochrane Review on Personal Protective Equipment for healthcare staff;
- All of this evidence is translated in up to 12 other languages to promote its global accessibility and use; and Cochrane Reviews are also being made openly available on the Wiley Online Library along with other relevant Wiley content;
- Cochrane’s ‘COVID-19 Study Register’ of primary research studies, in consultation with WHO, which has become one of the largest and most sophisticated registers in the world;
- The April 2020 issue of the Cochrane Library App, featuring abridged versions of Cochrane Reviews relevant for COVID-19 (available from Google Play (Android devices) or the App Store (iPhone and iPad));
- The Cochrane Library Journal Club (Issue #97), focusing on a Cochrane Review related to COVID-19 response preparation.
All of this material – and all of Cochrane’s future COVID-19 related evidence – will continue to be freely available to everyone, everywhere on the Cochrane Library (full text) and at Cochrane.org. Cochrane and Wiley will also continue to provide free one-click access to the complete Cochrane Library for those living in 126 Low- and Middle-Income Countries.
Cochrane’s Editor in Chief, Karla Soares Weiser said: “To assist efforts to contain and mitigate the rapidly evolving Covid-19 pandemic, we know that access to science research is vital. We have been amazed and humbled by the staggering response from Cochrane’s community Groups across the world who wish to contribute and engage with our efforts to date. We will be continuing to work on new ideas to make our content accessible to facilitate the sharing of high-quality, trusted health information and knowledge during these hugely challenging times.”
Read full details of Cochrane’s response to COVID-19 here.